Skip to Main Content

Try STAT+ TODAY

microbiome

Most Read

First Opinion Andrew Thomson, Brian Carpenter and Robert Broadnax

Developers of microbiome-based drugs face challenges. There are ways to overcome them

Biotech Erin Brodwin

SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud

Health Kate Sheridan

OpenBiome to wind down stool bank operations

In the Lab Kate Sheridan

New research underscores the link between multiple sclerosis and the gut microbiome

Health Kate Sheridan

One dead, four hospitalized after receiving OpenBiome stool transplants

Opinions+ Peter Bak

Microbiome drug development: a rapidly evolving field

Health Kate Sheridan

Massachusetts General Hospital oversaw trial that led to the first death from a fecal transplant, a new paper shows

Health Kate Sheridan

Your sexual partners can change your microbiome, a new study in mice finds

All Coverage

Biotech Kate Sheridan

Seres Therapeutics’ microbiome therapy for ulcerative colitis falls short in Phase 2 trial

Biotech Kate Sheridan

Nestlé Health Science will split profits from Seres microbiome drug, if it’s approved

advertisement

Health Kate Sheridan and Hyacinth Empinado

Watch: What’s the deal with fecal transplants?

Biotech Kate Sheridan

The field is exploding, but microbiome therapeutics still face a wave of challenges

Biotech Kate Sheridan

Microbiome company Finch Therapeutics begins trading publicly, quietly shuffles one of its executives

Biotech Kate Sheridan

Fecal matter transplants could help certain cancer drugs work in more people, study shows

Biotech Kate Sheridan

Months of limbo at OpenBiome put fecal matter transplants on hold across the country

Biotech Kate Sheridan

Seres announces positive late-stage results for its microbe-based drug

Biotech Kate Sheridan

Finch touts positive results for its microbiome pill for C. diff infections

Health Natalya Ortolano

A patient’s microbiome could have a major impact on how drugs affect them, new research confirms

In the Lab Elizabeth Cooney

Bacteria are widespread in tumors, forming distinct populations depending on the cancer type

Biotech Kate Sheridan

‘Good’ bacteria could help fight a common vaginal infection, new data show

Biotech Kate Sheridan

Rebiotix unveils positive — but preliminary — data on its microbiome drug for C. diff infections

Health Kate Sheridan

Within months of birth, some pathogens are detectable in infants’ guts, new research shows

Health Kate Sheridan

CDC credits a sharp decline in C. diff infections to checklists and better antibiotic stewardship

Biotech Kate Sheridan

Despite coronavirus disruption, major microbiome companies are cautiously optimistic about upcoming data

Biotech Rebecca Robbins

Microbial signatures in the blood could offer new avenue for liquid biopsies to detect cancer

Biotech Kate Sheridan

Microbiome-based drug makers are hoping new late-stage data will pull the field out of the shadows

Biotech Erin Brodwin

Bankrupt uBiome preliminarily sells patents for 1% of the poop-testing startup’s original valuation

Biotech Kate Sheridan

After an unprecedented death, FDA is offered divergent forecasts on future of fecal transplants

Biotech Kate Sheridan

FDA to consider new evidence, risks behind fecal matter transplants for C. diff treatment

Biotech Kate Sheridan

The next frontier for the microbiome: vaginal fluid transplants that take aim at a common condition

Pharmalot Elizabeth Cooney

Pharmalittle: Medicare will cover CAR-T; Trump health care overhaul in the wings

Biotech Megan Thielking

Biotech, but make it beauty: Startups look to viruses and bacteria for the next generation of skin care

In the Lab Shraddha Chakradhar

Using a more diverse microbiome, scientists look to create a better lab mouse